MedPath

Effect of the New Definition of Epilepsies of the ILAE of 2014 on the Diagnosis After the First Seizure

Recruiting
Conditions
Seizure, Epileptic
Neuropsychology
Outcome
Registration Number
NCT06836687
Lead Sponsor
University Hospital Marburg
Brief Summary

The present study is a prospective study on the development of seizure frequency, medication adherence, quality of life and cognitive performance after a first epileptic seizure using the new diagnostic criteria for epilepsy of the International League Against Epilepsy of 2014 at the time of diagnosis.

Detailed Description

The new diagnostic criteria for epilepsy, which have been in place since 2014, suggest that due to the improved possibilities for early diagnosis and treatment - particularly as a result of improved imaging diagnostics - changes in the incidence rates and severity of the course of epilepsies with different etiologies can be expected.

The group of epilepsies with unclear etiology should now be smaller than in previous studies. The MRI- and EEG-positive patients can now be identified as having structural epilepsy based on the type of lesion, which was not possible in previous studies without differentiated imaging. The fact that these patients can now be treated before a patients can now be treated before a second seizure, the risk of recurrence and the health economic costs should also be reduced and have a positive effect on maintaining cognitive performance and quality of life after a first epileptic seizure.

The aim of the study is to record the consequences of the new epilepsy diagnostic criteria in terms of outcome and treatment. In addition, the investigators will use a questionnaire battery and neuropsychological testing to record the potential neuropsychological deficits, financial and socio-medical consequences of a first seizure or early-stage epilepsy.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Completion of the 18th year of life
  • first epileptic seizure
  • Ability to understand the patient information and to give written consent
  • Written consent for voluntary participation in the study
Exclusion Criteria
  • Chronic drug or alcohol abuse in the last two years

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of seizure recurrency10 Years

Seizure recurrency is recorded 6 months, 1 year, 3 years, 5 years and 10 years after the first seizure

Secondary Outcome Measures
NameTimeMethod
Relationsship status10 years

Relationship status (single, maried, divorced) is assessed after the first attack, after 6 months, 1, 3, 5 and 10 years.

Wechsler Adult Intelligence Scale - WAIS IV10 Years

Wechsler Adult Intelligence Scale - WAIS IV at baseline and then after 1 years, 5 years and 10 years after the first seizure:

Intelligence quotient (40 to 160)

employment10 years

Currently working as employee or independent, retirement or long-time sick-leave at the first attack, after 6 months, 1, 3, 5 and 10 years.

Salary10 years

Gross salary in Euro at the first attack, after 6 months, 1, 3, 5 and 10 years.

Driving restriction10 Years

Fitness to drive (yes/no) is assessed after the first attack, after 6 months, 1, 3, 5 and 10 years.

Verbale Lern- und Merkfähigkeitstest10 years

Verbale Lern- und Merkfähigkeitstest - VLMT (Helmstaedter, Lendt, \& Lux, 2001) at baseline and then after 1 years, 5 years and 10 years after the first seizure:

0 to 135 points, O worst, 135 best possible result.

Regensburger Wortflüssigkeits-Test10 Years

Regensburger Wortflüssigkeits-Test - RWT (Aschenbrenner, Tucha, \& Lange, 2000) at baseline and then after 1 years, 5 years and 10 years after the first seizure:

Number of words starting with one asked letter, that can be said in 2 minutes (typically between 0 and 50)

Copy and recall of the Rey-Osterrieth Figure10 Years

Copy and recall of the Rey-Osterrieth Figure (Berry, Allen, \& Schmitt, 1991) at baseline and then after 1 years, 5 years and 10 years after the first seizure:

0 to 36 points. 0 worst possible result, 36 best possible result.

Trailmaking Test A & B10 Years

Trailmaking Test A \& B (Tombaugh, 2004) at baseline and then after 1 years, 5 years and 10 years after the first seizure:

individual time to absolve the test in seconds

TAP10 Years

Test for Attentional Performance - TAP (Zimmermann \& Fimm, 2002) at baseline and then after 1 years, 5 years and 10 years after the first seizure:

reaction time in ms, standard deviation of the reaction time, ratio of errors ratio of correct reactions

Trial Locations

Locations (1)

c/o Klinik für Neurologie

🇩🇪

Marburg, Hessen, Germany

c/o Klinik für Neurologie
🇩🇪Marburg, Hessen, Germany
Lena Habermehl, MD
Contact
00496421-5865435
lhaberme@med.uni-marburg.de
Susanne Knake, MD
Contact
00496421-5865435
knake@med.uni-marburg.de

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.